This study compares two eye drops, **Bimatoprost Ophthalmic Solution 0.01%** and **LUMIGAN®**, for treating a condition called **chronic open-angle glaucoma** or **ocular hypertension**. These conditions lead to increased pressure in the eyes, which can damage vision. Participants will be randomly assigned to use one of the drops every night at 10:00 pm for 42 days in both eyes. Researchers will check eye pressure after 2 weeks and 6 weeks to see how well each treatment works.

To be part of the study, you must be 18 or older, have specific eye conditions, and meet other health criteria. You should not have any severe eye diseases or be using certain medications. Pregnant or breastfeeding women, and those planning to become pregnant, cannot participate.

• Duration: 42-day treatment period.
• Visits: Clinical evaluations throughout the study.
• Eligibility: Specific health and lifestyle criteria must be met.